Day One Biopharmaceuticals Inc (DAWN)
17.17
-0.40
(-2.28%)
USD |
NASDAQ |
May 03, 16:00
17.15
-0.02
(-0.12%)
After-Hours: 20:00
Day One Biopharmaceuticals Price to Book Value: 4.330 for May 3, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 03, 2024 | 4.330 |
| May 02, 2024 | 4.430 |
| May 01, 2024 | 4.461 |
| April 30, 2024 | 4.312 |
| April 29, 2024 | 4.156 |
| April 26, 2024 | 3.762 |
| April 25, 2024 | 3.331 |
| April 24, 2024 | 3.830 |
| April 23, 2024 | 4.196 |
| April 22, 2024 | 3.878 |
| April 19, 2024 | 3.772 |
| April 18, 2024 | 3.972 |
| April 17, 2024 | 3.745 |
| April 16, 2024 | 3.684 |
| April 15, 2024 | 3.492 |
| April 12, 2024 | 3.472 |
| April 11, 2024 | 3.545 |
| April 10, 2024 | 3.634 |
| April 09, 2024 | 3.626 |
| April 08, 2024 | 3.520 |
| April 05, 2024 | 3.674 |
| April 04, 2024 | 3.581 |
| April 03, 2024 | 3.934 |
| April 02, 2024 | 3.994 |
| April 01, 2024 | 4.075 |
| Date | Value |
|---|---|
| March 28, 2024 | 4.166 |
| March 27, 2024 | 3.982 |
| March 26, 2024 | 3.914 |
| March 25, 2024 | 3.788 |
| March 22, 2024 | 3.921 |
| March 21, 2024 | 3.798 |
| March 20, 2024 | 3.699 |
| March 19, 2024 | 3.480 |
| March 18, 2024 | 3.513 |
| March 15, 2024 | 3.629 |
| March 14, 2024 | 3.578 |
| March 13, 2024 | 3.755 |
| March 12, 2024 | 3.714 |
| March 11, 2024 | 3.820 |
| March 08, 2024 | 3.924 |
| March 07, 2024 | 3.914 |
| March 06, 2024 | 3.979 |
| March 05, 2024 | 4.206 |
| March 04, 2024 | 4.259 |
| March 01, 2024 | 4.403 |
| February 29, 2024 | 4.219 |
| February 28, 2024 | 4.244 |
| February 27, 2024 | 4.383 |
| February 26, 2024 | 3.946 |
| February 23, 2024 | 3.828 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.364
Minimum
May 27 2022
5.546
Maximum
Sep 01 2021
3.601
Average
3.633
Median
Price to Book Value Benchmarks
| Revolution Medicines Inc | 3.625 |
| Zentalis Pharmaceuticals Inc | 1.900 |
| Perspective Therapeutics Inc | 14.13 |
| Electromed Inc | 3.946 |
| Xtant Medical Holdings Inc | 2.156 |
Price to Book Value Related Metrics
| Price | 17.17 |
| Earnings Yield | -13.86% |
| Market Cap | 1.500B |